The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus

One of the key features of chronic hepatitis B virus (HBV) infection is the inability to mount sufficient and coordinated adaptive immune responses against HBV. Recent studies on HBV-specific B cells and antibody to hepatitis B surface antigen (anti-HBs) have shed light on their role in the pathogen...

Full description

Saved in:
Bibliographic Details
Main Authors: Ling Ding, Jiaquan Huang, Shuaiwen Huang
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2445283
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841560369247551488
author Ling Ding
Jiaquan Huang
Shuaiwen Huang
author_facet Ling Ding
Jiaquan Huang
Shuaiwen Huang
author_sort Ling Ding
collection DOAJ
description One of the key features of chronic hepatitis B virus (HBV) infection is the inability to mount sufficient and coordinated adaptive immune responses against HBV. Recent studies on HBV-specific B cells and antibody to hepatitis B surface antigen (anti-HBs) have shed light on their role in the pathogenesis of chronic hepatitis B (CHB). Anti-HBs is recognized as a protective immune marker, both for HBV infection clearance and following vaccination, and it is also considered an important indicator of functional cure for CHB. Notably, functional impairment of HBV-specific B cells may be reversible. The restoration of HBV-specific B cell function, along with the induction of an anti-HBs antibody response, is regarded as pivotal for terminating chronic HBV infection and achieving functional cure. This article reviews the significance of anti-HBs in both the infection and clearance of HBV, and discusses the potential of neutralizing antibodies and therapeutic vaccines as promising future strategies.
format Article
id doaj-art-cfb7af5e559e4f749462291b6fffdc91
institution Kabale University
issn 2164-5515
2164-554X
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj-art-cfb7af5e559e4f749462291b6fffdc912025-01-04T07:58:17ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2025-12-0121110.1080/21645515.2024.2445283The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virusLing Ding0Jiaquan Huang1Shuaiwen Huang2Department of General Practice, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of General Practice, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaOne of the key features of chronic hepatitis B virus (HBV) infection is the inability to mount sufficient and coordinated adaptive immune responses against HBV. Recent studies on HBV-specific B cells and antibody to hepatitis B surface antigen (anti-HBs) have shed light on their role in the pathogenesis of chronic hepatitis B (CHB). Anti-HBs is recognized as a protective immune marker, both for HBV infection clearance and following vaccination, and it is also considered an important indicator of functional cure for CHB. Notably, functional impairment of HBV-specific B cells may be reversible. The restoration of HBV-specific B cell function, along with the induction of an anti-HBs antibody response, is regarded as pivotal for terminating chronic HBV infection and achieving functional cure. This article reviews the significance of anti-HBs in both the infection and clearance of HBV, and discusses the potential of neutralizing antibodies and therapeutic vaccines as promising future strategies.https://www.tandfonline.com/doi/10.1080/21645515.2024.2445283Hepatitis B virushepatitis B surface antibodyfunctional cureHBV-specific B cellstherapeutic vaccines
spellingShingle Ling Ding
Jiaquan Huang
Shuaiwen Huang
The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
Human Vaccines & Immunotherapeutics
Hepatitis B virus
hepatitis B surface antibody
functional cure
HBV-specific B cells
therapeutic vaccines
title The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
title_full The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
title_fullStr The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
title_full_unstemmed The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
title_short The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
title_sort significance of antibody to hepatitis b surface antigen in infection and clearance of hepatitis b virus
topic Hepatitis B virus
hepatitis B surface antibody
functional cure
HBV-specific B cells
therapeutic vaccines
url https://www.tandfonline.com/doi/10.1080/21645515.2024.2445283
work_keys_str_mv AT lingding thesignificanceofantibodytohepatitisbsurfaceantigenininfectionandclearanceofhepatitisbvirus
AT jiaquanhuang thesignificanceofantibodytohepatitisbsurfaceantigenininfectionandclearanceofhepatitisbvirus
AT shuaiwenhuang thesignificanceofantibodytohepatitisbsurfaceantigenininfectionandclearanceofhepatitisbvirus
AT lingding significanceofantibodytohepatitisbsurfaceantigenininfectionandclearanceofhepatitisbvirus
AT jiaquanhuang significanceofantibodytohepatitisbsurfaceantigenininfectionandclearanceofhepatitisbvirus
AT shuaiwenhuang significanceofantibodytohepatitisbsurfaceantigenininfectionandclearanceofhepatitisbvirus